Prostate cancer

Simultaneous Treatment with Statins and Aspirin Reduces the Risk of Prostate Cancer Detection and Tumorigenic Properties in Prostate Cancer Cell Lines

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4306438/

The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2

https://pubmed.ncbi.nlm.nih.gov/10753955/

Niclosamide exerts anticancer effects through inhibition of the FOXM1-mediated DNA damage response in prostate cancer

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8263667/

Green tea extract for prevention of prostate cancer progression in patients on active surveillance

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6340872/

Sulforaphane and Its Protective Role in Prostate Cancer: A Mechanistic Approach

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10138336/

Sulforaphane Combined with Vitamin D Induces Cytotoxicity Mediated by Oxidative Stress, DNA Damage, Autophagy, and JNK/MAPK Pathway Modulation in Human Prostate Tumor Cells

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10302480/

Targeting the SPOCK1-snail/slug axis-mediated epithelial-to-mesenchymal transition by apigenin contributes to the repression of prostate cancer metastasis

https://jeccr.biomedcentral.com/articles/10.1186/s13046-019-1247-3

Indole-3-Carbinol inhibition of androgen receptor expression and downregulation of androgen responsiveness in human prostate cancer cells

https://pubmed.ncbi.nlm.nih.gov/15958518/

Honokiol Inhibits Androgen Receptor Activity in Prostate Cancer Cells

https://pubmed.ncbi.nlm.nih.gov/24338950/

Berberine Suppresses Androgen Receptor Signaling in Prostate Cancer

https://pubmed.ncbi.nlm.nih.gov/21613449/

Graviola inhibits hypoxia-induced NADPH oxidase activity in prostate cancer cells reducing their proliferation and clonogenicity

https://www.nature.com/articles/srep23135

Targeting ASCT2-mediated glutamine uptake blocks prostate cancer growth and tumour development

https://pubmed.ncbi.nlm.nih.gov/25693838/

Tamoxifen and raloxifene suppress the proliferation of estrogen receptor-negative cells through inhibition of glutamine uptake

https://pubmed.ncbi.nlm.nih.gov/20383709/

Bromocriptine monotherapy overcomes prostate cancer chemoresistance in preclinical models

https://www.sciencedirect.com/science/article/pii/S1936523323000931

Betaine suppresses cell proliferation by increasing oxidative stress–mediated apoptosis and inflammation in DU-145 human prostate cancer cell line

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6717232

Natural product myricetin is a pan-KDM4 inhibitor which with poly lactic-co-glycolic acid formulation effectively targets castration-resistant prostate cancer

https://link.springer.com/article/10.1186/s12929-022-00812-3

Drastic Synergy of Lovastatin and Antrodia camphorata Extract Combination against PC3 Androgen-Refractory Prostate Cancer Cells, Accompanied by AXL and Stemness Molecules Inhibition

https://www.mdpi.com/2072-6643/15/21/4493

Anticancer Effect by Combined Treatment of Artemisia annua L. Polyphenols and Docetaxel in DU145 Prostate Cancer Cells and HCT116 Colorectal Cancer Cells

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10888123/